Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rhinitis | 56 | 2023 | 691 | 15.420 |
Why?
|
Sinusitis | 63 | 2023 | 923 | 14.490 |
Why?
|
Nasal Polyps | 37 | 2023 | 360 | 12.370 |
Why?
|
Nasal Mucosa | 28 | 2021 | 373 | 7.890 |
Why?
|
Endoscopy | 54 | 2023 | 1785 | 7.210 |
Why?
|
Orbital Neoplasms | 12 | 2023 | 225 | 5.450 |
Why?
|
Paranasal Sinuses | 22 | 2023 | 250 | 5.370 |
Why?
|
Orbit | 15 | 2023 | 426 | 3.720 |
Why?
|
Skull Base | 14 | 2019 | 306 | 3.490 |
Why?
|
Exosomes | 9 | 2020 | 417 | 3.410 |
Why?
|
Hemangioma, Cavernous | 6 | 2023 | 110 | 3.370 |
Why?
|
Salivary Cystatins | 4 | 2022 | 10 | 2.950 |
Why?
|
Nasal Cavity | 11 | 2024 | 313 | 2.520 |
Why?
|
Surgical Flaps | 9 | 2018 | 1640 | 2.460 |
Why?
|
Chronic Disease | 53 | 2023 | 9146 | 2.260 |
Why?
|
Aerosols | 10 | 2021 | 625 | 2.250 |
Why?
|
Dacryocystorhinostomy | 6 | 2021 | 72 | 2.180 |
Why?
|
Nose | 8 | 2024 | 509 | 2.030 |
Why?
|
Frontal Sinus | 3 | 2020 | 50 | 1.860 |
Why?
|
Otolaryngology | 5 | 2021 | 645 | 1.800 |
Why?
|
Eosinophils | 7 | 2023 | 955 | 1.740 |
Why?
|
Verapamil | 7 | 2023 | 244 | 1.700 |
Why?
|
Mucus | 7 | 2023 | 321 | 1.680 |
Why?
|
Laser Therapy | 9 | 2013 | 1072 | 1.630 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 7 | 2020 | 312 | 1.520 |
Why?
|
Blood-Brain Barrier | 10 | 2022 | 1017 | 1.480 |
Why?
|
Osteitis | 4 | 2018 | 33 | 1.430 |
Why?
|
Ethmoid Bone | 3 | 2020 | 35 | 1.330 |
Why?
|
Nose Diseases | 2 | 2020 | 79 | 1.290 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 6 | 2011 | 80 | 1.260 |
Why?
|
Blood Loss, Surgical | 3 | 2016 | 662 | 1.200 |
Why?
|
Epistaxis | 3 | 2016 | 111 | 1.130 |
Why?
|
Administration, Intranasal | 7 | 2023 | 446 | 1.080 |
Why?
|
Cadaver | 13 | 2020 | 1337 | 1.070 |
Why?
|
Graves Ophthalmopathy | 3 | 2017 | 117 | 1.060 |
Why?
|
Natural Orifice Endoscopic Surgery | 5 | 2020 | 118 | 1.040 |
Why?
|
Palate, Hard | 3 | 2018 | 57 | 1.020 |
Why?
|
Therapeutic Irrigation | 4 | 2020 | 301 | 0.980 |
Why?
|
Glucocorticoids | 5 | 2020 | 2107 | 0.970 |
Why?
|
Nasal Obstruction | 5 | 2019 | 151 | 0.960 |
Why?
|
Olfaction Disorders | 4 | 2023 | 222 | 0.950 |
Why?
|
Epithelial Cells | 7 | 2018 | 3690 | 0.950 |
Why?
|
Drug Delivery Systems | 9 | 2022 | 2219 | 0.930 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 3 | 2023 | 253 | 0.930 |
Why?
|
Proteome | 5 | 2020 | 1799 | 0.930 |
Why?
|
Nasal Septum | 6 | 2019 | 127 | 0.920 |
Why?
|
Decompression, Surgical | 4 | 2017 | 594 | 0.920 |
Why?
|
Steroids | 3 | 2023 | 930 | 0.910 |
Why?
|
Brain-Derived Neurotrophic Factor | 3 | 2024 | 604 | 0.900 |
Why?
|
Coronavirus Infections | 5 | 2020 | 3133 | 0.880 |
Why?
|
Pneumonia, Viral | 5 | 2020 | 3240 | 0.880 |
Why?
|
Th2 Cells | 3 | 2018 | 1061 | 0.860 |
Why?
|
Pregnancy-Associated Plasma Protein-A | 2 | 2020 | 55 | 0.860 |
Why?
|
Turbinates | 6 | 2020 | 68 | 0.830 |
Why?
|
Fluorescein | 3 | 2020 | 171 | 0.830 |
Why?
|
Nasal Decongestants | 3 | 2021 | 28 | 0.820 |
Why?
|
Humans | 160 | 2024 | 744343 | 0.800 |
Why?
|
Povidone-Iodine | 1 | 2020 | 59 | 0.750 |
Why?
|
Nasal Lavage | 2 | 2019 | 11 | 0.740 |
Why?
|
Olfactory Mucosa | 1 | 2021 | 98 | 0.740 |
Why?
|
Oculomotor Muscles | 2 | 2016 | 371 | 0.710 |
Why?
|
Smell | 3 | 2021 | 244 | 0.700 |
Why?
|
Administration, Topical | 7 | 2023 | 690 | 0.700 |
Why?
|
Rhinoplasty | 4 | 2019 | 226 | 0.670 |
Why?
|
Peptide Hydrolases | 2 | 2022 | 634 | 0.660 |
Why?
|
Sterilization | 1 | 2019 | 133 | 0.660 |
Why?
|
Peroxiredoxins | 1 | 2018 | 51 | 0.660 |
Why?
|
Ophthalmic Artery | 2 | 2020 | 60 | 0.650 |
Why?
|
Equipment Contamination | 1 | 2019 | 185 | 0.640 |
Why?
|
Off-Label Use | 1 | 2020 | 169 | 0.640 |
Why?
|
Chitosan | 2 | 2010 | 141 | 0.630 |
Why?
|
Anti-Infective Agents, Local | 1 | 2020 | 250 | 0.630 |
Why?
|
Disease Transmission, Infectious | 2 | 2020 | 547 | 0.630 |
Why?
|
Platelet Membrane Glycoproteins | 1 | 2018 | 293 | 0.620 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2019 | 179 | 0.610 |
Why?
|
Nasolacrimal Duct | 4 | 2021 | 74 | 0.610 |
Why?
|
Enterotoxins | 2 | 2015 | 368 | 0.580 |
Why?
|
Biological Products | 3 | 2020 | 860 | 0.580 |
Why?
|
Craniotomy | 3 | 2018 | 729 | 0.580 |
Why?
|
Dacryocystitis | 1 | 2017 | 70 | 0.580 |
Why?
|
Encephalocele | 1 | 2017 | 136 | 0.570 |
Why?
|
Virus Diseases | 1 | 2022 | 711 | 0.560 |
Why?
|
Skull Base Neoplasms | 3 | 2024 | 284 | 0.560 |
Why?
|
Mucous Membrane | 3 | 2016 | 673 | 0.560 |
Why?
|
Glial Cell Line-Derived Neurotrophic Factor | 1 | 2016 | 65 | 0.550 |
Why?
|
Pseudomonas Infections | 4 | 2018 | 613 | 0.540 |
Why?
|
Pandemics | 6 | 2021 | 8388 | 0.540 |
Why?
|
Up-Regulation | 8 | 2020 | 4217 | 0.540 |
Why?
|
Adult | 51 | 2023 | 214055 | 0.540 |
Why?
|
Hemostasis, Surgical | 1 | 2016 | 128 | 0.530 |
Why?
|
Models, Anatomic | 1 | 2019 | 691 | 0.530 |
Why?
|
Brain Concussion | 2 | 2024 | 1320 | 0.520 |
Why?
|
Frontal Sinusitis | 1 | 2015 | 19 | 0.520 |
Why?
|
Staphylococcus aureus | 3 | 2018 | 1451 | 0.520 |
Why?
|
Middle Aged | 52 | 2023 | 213383 | 0.520 |
Why?
|
Meningeal Neoplasms | 2 | 2024 | 1241 | 0.520 |
Why?
|
Sphenoid Bone | 3 | 2018 | 172 | 0.520 |
Why?
|
Hemostatic Techniques | 1 | 2016 | 116 | 0.520 |
Why?
|
Aneurysm, False | 1 | 2018 | 276 | 0.520 |
Why?
|
Itraconazole | 1 | 2015 | 43 | 0.520 |
Why?
|
Blood Coagulation Disorders | 1 | 2018 | 337 | 0.520 |
Why?
|
Prednisolone | 2 | 2023 | 334 | 0.520 |
Why?
|
Epinephrine | 2 | 2016 | 792 | 0.520 |
Why?
|
Dexamethasone | 3 | 2014 | 1951 | 0.520 |
Why?
|
Maxillary Sinus | 3 | 2015 | 180 | 0.510 |
Why?
|
Subarachnoid Space | 1 | 2015 | 79 | 0.510 |
Why?
|
Craniofacial Abnormalities | 1 | 2017 | 315 | 0.510 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2020 | 780 | 0.510 |
Why?
|
Clarithromycin | 1 | 2015 | 86 | 0.500 |
Why?
|
Nose Deformities, Acquired | 1 | 2015 | 44 | 0.500 |
Why?
|
Ultraviolet Rays | 1 | 2019 | 1060 | 0.490 |
Why?
|
Cell Membrane Permeability | 1 | 2016 | 590 | 0.490 |
Why?
|
Respiratory Mucosa | 1 | 2017 | 427 | 0.480 |
Why?
|
Respiratory System | 1 | 2017 | 557 | 0.480 |
Why?
|
Prednisone | 2 | 2020 | 1574 | 0.480 |
Why?
|
Oculomotor Nerve | 1 | 2014 | 74 | 0.470 |
Why?
|
Male | 60 | 2024 | 350118 | 0.470 |
Why?
|
Absorbable Implants | 2 | 2022 | 342 | 0.460 |
Why?
|
Hypersensitivity | 2 | 2024 | 1102 | 0.460 |
Why?
|
Hemostatics | 1 | 2016 | 229 | 0.460 |
Why?
|
Anti-Bacterial Agents | 6 | 2021 | 7181 | 0.450 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2018 | 838 | 0.450 |
Why?
|
Desensitization, Immunologic | 1 | 2018 | 483 | 0.450 |
Why?
|
Cell Adhesion Molecules | 1 | 2019 | 1602 | 0.440 |
Why?
|
Respiratory Tract Infections | 1 | 2020 | 961 | 0.440 |
Why?
|
Research Support as Topic | 1 | 2017 | 705 | 0.440 |
Why?
|
Parkinsonian Disorders | 1 | 2016 | 275 | 0.440 |
Why?
|
Osteoblasts | 1 | 2018 | 1166 | 0.440 |
Why?
|
Dopamine beta-Hydroxylase | 1 | 2012 | 75 | 0.430 |
Why?
|
Female | 56 | 2024 | 380194 | 0.430 |
Why?
|
Rabbits | 9 | 2013 | 4894 | 0.420 |
Why?
|
Central Nervous System | 2 | 2021 | 1357 | 0.420 |
Why?
|
Choline O-Acetyltransferase | 1 | 2012 | 150 | 0.410 |
Why?
|
Tissue and Organ Harvesting | 1 | 2015 | 369 | 0.410 |
Why?
|
Antiviral Agents | 2 | 2022 | 2987 | 0.410 |
Why?
|
Drug Dosage Calculations | 1 | 2012 | 114 | 0.400 |
Why?
|
Pterygopalatine Fossa | 1 | 2011 | 9 | 0.400 |
Why?
|
Dibenzocycloheptenes | 3 | 2015 | 27 | 0.400 |
Why?
|
Gastrointestinal Tract | 1 | 2017 | 814 | 0.390 |
Why?
|
Intraoperative Complications | 2 | 2016 | 1198 | 0.390 |
Why?
|
Calcium Channel Blockers | 1 | 2014 | 690 | 0.390 |
Why?
|
Antifungal Agents | 2 | 2015 | 730 | 0.390 |
Why?
|
Mucocele | 1 | 2011 | 49 | 0.390 |
Why?
|
Fluorescent Dyes | 4 | 2018 | 1917 | 0.390 |
Why?
|
Hemangioma | 1 | 2016 | 738 | 0.380 |
Why?
|
Biocompatible Materials | 2 | 2010 | 1736 | 0.380 |
Why?
|
Immunity, Innate | 2 | 2022 | 2958 | 0.380 |
Why?
|
Endoscopes | 3 | 2020 | 175 | 0.370 |
Why?
|
Headache | 1 | 2018 | 1226 | 0.370 |
Why?
|
Subdural Effusion | 1 | 2010 | 19 | 0.370 |
Why?
|
Quality of Life | 11 | 2024 | 12804 | 0.360 |
Why?
|
Nucleic Acids | 2 | 2022 | 182 | 0.360 |
Why?
|
Bone Transplantation | 1 | 2015 | 907 | 0.360 |
Why?
|
Prosthesis Implantation | 2 | 2016 | 642 | 0.350 |
Why?
|
Luminescent Measurements | 1 | 2012 | 405 | 0.350 |
Why?
|
Transferrin | 1 | 2011 | 295 | 0.350 |
Why?
|
Postoperative Complications | 9 | 2017 | 15295 | 0.350 |
Why?
|
Preoperative Care | 3 | 2016 | 2250 | 0.350 |
Why?
|
Pseudomonas aeruginosa | 3 | 2016 | 1219 | 0.340 |
Why?
|
Drug Implants | 1 | 2010 | 244 | 0.340 |
Why?
|
Neuroprotective Agents | 1 | 2016 | 941 | 0.340 |
Why?
|
Anti-Inflammatory Agents | 2 | 2020 | 1790 | 0.340 |
Why?
|
Human papillomavirus 6 | 1 | 2008 | 16 | 0.330 |
Why?
|
Substantia Nigra | 2 | 2024 | 353 | 0.330 |
Why?
|
Angiofibroma | 1 | 2009 | 68 | 0.330 |
Why?
|
Esophageal Perforation | 1 | 2008 | 69 | 0.320 |
Why?
|
Bacterial Load | 2 | 2019 | 153 | 0.320 |
Why?
|
Follow-Up Studies | 14 | 2018 | 39050 | 0.320 |
Why?
|
Case-Control Studies | 10 | 2021 | 21746 | 0.310 |
Why?
|
Brain | 7 | 2022 | 26385 | 0.310 |
Why?
|
Suture Techniques | 3 | 2011 | 798 | 0.310 |
Why?
|
Cell Membrane | 1 | 2017 | 3748 | 0.310 |
Why?
|
Central Nervous System Diseases | 2 | 2022 | 518 | 0.310 |
Why?
|
Papilloma | 1 | 2008 | 148 | 0.300 |
Why?
|
Liposomes | 2 | 2023 | 759 | 0.300 |
Why?
|
Barium Sulfate | 1 | 2007 | 180 | 0.300 |
Why?
|
Treatment Outcome | 20 | 2024 | 63114 | 0.300 |
Why?
|
Autonomic Nervous System | 1 | 2012 | 671 | 0.300 |
Why?
|
Drug Therapy | 1 | 2010 | 497 | 0.290 |
Why?
|
Cognition Disorders | 1 | 2021 | 4043 | 0.290 |
Why?
|
Proteomics | 4 | 2022 | 3638 | 0.280 |
Why?
|
Risk | 4 | 2020 | 9687 | 0.280 |
Why?
|
Interleukin-8 | 3 | 2015 | 690 | 0.280 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2009 | 286 | 0.280 |
Why?
|
Acrospiroma | 1 | 2006 | 13 | 0.280 |
Why?
|
Polysaccharides | 1 | 2013 | 1053 | 0.270 |
Why?
|
Oxyphil Cells | 1 | 2006 | 57 | 0.270 |
Why?
|
Young Adult | 12 | 2019 | 56430 | 0.270 |
Why?
|
Cytokines | 5 | 2022 | 7322 | 0.270 |
Why?
|
Nose Neoplasms | 1 | 2008 | 246 | 0.270 |
Why?
|
Nerve Growth Factors | 2 | 2020 | 574 | 0.270 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 2006 | 177 | 0.270 |
Why?
|
Bronchi | 1 | 2010 | 840 | 0.270 |
Why?
|
Quinolines | 3 | 2015 | 732 | 0.270 |
Why?
|
Optic Nerve | 2 | 2020 | 554 | 0.270 |
Why?
|
Hemorrhage | 1 | 2017 | 3461 | 0.270 |
Why?
|
Neutrophils | 1 | 2018 | 3719 | 0.270 |
Why?
|
Brain Diseases | 1 | 2015 | 1563 | 0.260 |
Why?
|
Biomedical Research | 2 | 2018 | 3309 | 0.260 |
Why?
|
Prospective Studies | 16 | 2023 | 53288 | 0.260 |
Why?
|
Imaging, Three-Dimensional | 2 | 2017 | 4042 | 0.250 |
Why?
|
Radiography | 5 | 2015 | 7023 | 0.250 |
Why?
|
Cells, Cultured | 7 | 2016 | 19229 | 0.250 |
Why?
|
Paranasal Sinus Diseases | 2 | 2016 | 116 | 0.250 |
Why?
|
Lung Injury | 1 | 2010 | 436 | 0.250 |
Why?
|
Parathyroid Neoplasms | 1 | 2006 | 245 | 0.250 |
Why?
|
Tomography, X-Ray Computed | 11 | 2020 | 20129 | 0.250 |
Why?
|
Interleukin-5 | 2 | 2015 | 273 | 0.250 |
Why?
|
Fluoresceins | 2 | 2015 | 235 | 0.240 |
Why?
|
Sweat Gland Neoplasms | 1 | 2006 | 108 | 0.240 |
Why?
|
Retrospective Studies | 18 | 2024 | 77449 | 0.240 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11031 | 0.240 |
Why?
|
Temporal Bone | 2 | 2020 | 661 | 0.240 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2017 | 3870 | 0.240 |
Why?
|
Eosinophilia | 2 | 2020 | 541 | 0.240 |
Why?
|
Trachea | 1 | 2010 | 1076 | 0.240 |
Why?
|
Aged | 25 | 2022 | 163280 | 0.240 |
Why?
|
Neovascularization, Pathologic | 1 | 2014 | 2635 | 0.230 |
Why?
|
Orbital Diseases | 2 | 2016 | 181 | 0.230 |
Why?
|
Mastoid | 2 | 2020 | 92 | 0.230 |
Why?
|
Animals | 22 | 2024 | 168757 | 0.230 |
Why?
|
Lipopolysaccharides | 4 | 2016 | 2216 | 0.230 |
Why?
|
Diplopia | 2 | 2015 | 200 | 0.230 |
Why?
|
Organ Culture Techniques | 2 | 2015 | 813 | 0.220 |
Why?
|
Poly I-C | 1 | 2022 | 115 | 0.220 |
Why?
|
Toll-Like Receptor 3 | 1 | 2022 | 91 | 0.210 |
Why?
|
Cautery | 2 | 2020 | 72 | 0.210 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2007 | 477 | 0.210 |
Why?
|
Drug-Eluting Stents | 1 | 2009 | 753 | 0.210 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2022 | 190 | 0.200 |
Why?
|
Neurodegenerative Diseases | 2 | 2022 | 1061 | 0.200 |
Why?
|
Inflammation | 5 | 2022 | 10638 | 0.200 |
Why?
|
Deglutition Disorders | 1 | 2007 | 605 | 0.200 |
Why?
|
Severity of Illness Index | 6 | 2019 | 15540 | 0.200 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2024 | 234 | 0.200 |
Why?
|
Dissection | 2 | 2015 | 295 | 0.200 |
Why?
|
Neural Pathways | 1 | 2012 | 2972 | 0.200 |
Why?
|
Prognosis | 6 | 2019 | 29063 | 0.190 |
Why?
|
Cysts | 1 | 2006 | 678 | 0.190 |
Why?
|
Lacrimal Duct Obstruction | 1 | 2021 | 48 | 0.190 |
Why?
|
Rhinitis, Allergic, Perennial | 2 | 2011 | 57 | 0.190 |
Why?
|
Biological Transport | 2 | 2017 | 2118 | 0.190 |
Why?
|
Sheep | 2 | 2017 | 1437 | 0.190 |
Why?
|
Staphylococcal Infections | 1 | 2010 | 1400 | 0.190 |
Why?
|
Feasibility Studies | 5 | 2012 | 5078 | 0.190 |
Why?
|
Sneezing | 1 | 2020 | 17 | 0.190 |
Why?
|
Insulin-Like Growth Factor Binding Protein 4 | 1 | 2020 | 26 | 0.180 |
Why?
|
Insulin-Like Growth Factor Binding Protein 5 | 1 | 2020 | 27 | 0.180 |
Why?
|
Asymptomatic Infections | 1 | 2020 | 128 | 0.180 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2014 | 903 | 0.180 |
Why?
|
Models, Animal | 3 | 2022 | 2171 | 0.180 |
Why?
|
Exophthalmos | 1 | 2020 | 97 | 0.180 |
Why?
|
Equipment and Supplies, Hospital | 1 | 2019 | 57 | 0.170 |
Why?
|
Bacteria | 3 | 2020 | 2114 | 0.170 |
Why?
|
Acute Disease | 4 | 2021 | 7149 | 0.170 |
Why?
|
Immunohistochemistry | 5 | 2019 | 11366 | 0.170 |
Why?
|
Disease Models, Animal | 8 | 2022 | 18029 | 0.170 |
Why?
|
Cough | 1 | 2023 | 555 | 0.170 |
Why?
|
Preoperative Period | 2 | 2020 | 549 | 0.170 |
Why?
|
Detergents | 1 | 2019 | 230 | 0.170 |
Why?
|
False Negative Reactions | 1 | 2020 | 588 | 0.170 |
Why?
|
Discriminant Analysis | 1 | 2019 | 235 | 0.170 |
Why?
|
Suction | 1 | 2020 | 267 | 0.170 |
Why?
|
Interleukin-6 | 3 | 2014 | 3200 | 0.170 |
Why?
|
Water Microbiology | 1 | 2019 | 117 | 0.170 |
Why?
|
Reoperation | 2 | 2019 | 4201 | 0.170 |
Why?
|
Otologic Surgical Procedures | 1 | 2020 | 145 | 0.170 |
Why?
|
Maxillary Sinusitis | 2 | 2009 | 39 | 0.170 |
Why?
|
Ear Diseases | 1 | 2020 | 170 | 0.160 |
Why?
|
Predictive Value of Tests | 3 | 2019 | 15076 | 0.160 |
Why?
|
Calgranulin A | 1 | 2018 | 79 | 0.160 |
Why?
|
Calgranulin B | 1 | 2018 | 84 | 0.160 |
Why?
|
Surgery, Computer-Assisted | 1 | 2006 | 1018 | 0.160 |
Why?
|
Microwaves | 1 | 2019 | 191 | 0.160 |
Why?
|
Depression | 1 | 2017 | 7766 | 0.160 |
Why?
|
Sphenoid Sinus | 1 | 2018 | 99 | 0.150 |
Why?
|
United States | 8 | 2020 | 69872 | 0.150 |
Why?
|
Orbital Implants | 1 | 2017 | 21 | 0.150 |
Why?
|
Nasopharynx | 1 | 2020 | 379 | 0.150 |
Why?
|
Neutrophil Activation | 1 | 2018 | 186 | 0.150 |
Why?
|
Disinfection | 1 | 2019 | 191 | 0.150 |
Why?
|
Eye Neoplasms | 1 | 2019 | 313 | 0.150 |
Why?
|
Rhinometry, Acoustic | 1 | 2017 | 8 | 0.150 |
Why?
|
Wounds and Injuries | 1 | 2010 | 2400 | 0.150 |
Why?
|
Growth Differentiation Factor 5 | 1 | 2016 | 35 | 0.150 |
Why?
|
Rats | 4 | 2024 | 24260 | 0.150 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2018 | 534 | 0.140 |
Why?
|
Ovalbumin | 1 | 2018 | 719 | 0.140 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2020 | 9239 | 0.140 |
Why?
|
Reference Values | 2 | 2016 | 4982 | 0.140 |
Why?
|
Manometry | 2 | 2008 | 445 | 0.140 |
Why?
|
Papillomavirus Infections | 1 | 2008 | 1587 | 0.140 |
Why?
|
Nasal Lavage Fluid | 2 | 2019 | 16 | 0.140 |
Why?
|
Radiopharmaceuticals | 1 | 2006 | 2645 | 0.140 |
Why?
|
Cell Count | 2 | 2018 | 1856 | 0.140 |
Why?
|
Surgical Sponges | 1 | 2016 | 46 | 0.140 |
Why?
|
Bacteriophages | 1 | 2019 | 356 | 0.140 |
Why?
|
Delphi Technique | 1 | 2019 | 778 | 0.140 |
Why?
|
Particle Size | 1 | 2020 | 1642 | 0.130 |
Why?
|
Postoperative Period | 2 | 2019 | 1842 | 0.130 |
Why?
|
Intubation | 1 | 2016 | 141 | 0.130 |
Why?
|
Ethmoid Sinusitis | 1 | 2015 | 25 | 0.130 |
Why?
|
Permeability | 2 | 2018 | 738 | 0.130 |
Why?
|
N-Acetylglucosaminyltransferases | 1 | 2016 | 171 | 0.130 |
Why?
|
Probiotics | 1 | 2019 | 351 | 0.130 |
Why?
|
Enophthalmos | 1 | 2015 | 34 | 0.130 |
Why?
|
Ethmoid Sinus | 1 | 2015 | 58 | 0.130 |
Why?
|
Meningioma | 1 | 2024 | 1209 | 0.130 |
Why?
|
Cluster Analysis | 2 | 2019 | 2715 | 0.130 |
Why?
|
Neurilemmoma | 1 | 2020 | 547 | 0.130 |
Why?
|
Fibrinogen | 1 | 2018 | 894 | 0.130 |
Why?
|
Eye Diseases | 1 | 2020 | 669 | 0.130 |
Why?
|
Specimen Handling | 1 | 2019 | 694 | 0.130 |
Why?
|
Allergens | 1 | 2022 | 1320 | 0.130 |
Why?
|
Administration, Oral | 2 | 2016 | 3913 | 0.120 |
Why?
|
World Health Organization | 1 | 2020 | 1318 | 0.120 |
Why?
|
Fibronectins | 1 | 2018 | 726 | 0.120 |
Why?
|
von Willebrand Factor | 1 | 2018 | 669 | 0.120 |
Why?
|
Retinal Cone Photoreceptor Cells | 1 | 2015 | 177 | 0.120 |
Why?
|
Wound Healing | 2 | 2017 | 2785 | 0.120 |
Why?
|
Mucormycosis | 1 | 2015 | 97 | 0.120 |
Why?
|
Disease Progression | 3 | 2019 | 13284 | 0.120 |
Why?
|
Endocrinology | 1 | 2020 | 443 | 0.120 |
Why?
|
Asthma, Aspirin-Induced | 1 | 2017 | 182 | 0.120 |
Why?
|
Contrast Media | 1 | 2007 | 5300 | 0.120 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2016 | 10943 | 0.120 |
Why?
|
Olfactory Pathways | 1 | 2015 | 121 | 0.120 |
Why?
|
Eye Infections, Fungal | 1 | 2015 | 110 | 0.120 |
Why?
|
Cyclosporins | 1 | 2014 | 220 | 0.120 |
Why?
|
Diagnosis, Differential | 4 | 2017 | 12959 | 0.120 |
Why?
|
Protease Inhibitors | 1 | 2018 | 791 | 0.120 |
Why?
|
Suppuration | 2 | 2018 | 56 | 0.120 |
Why?
|
Rhodamine 123 | 1 | 2013 | 38 | 0.120 |
Why?
|
Eye Infections, Bacterial | 1 | 2016 | 235 | 0.110 |
Why?
|
Aspergillosis | 1 | 2015 | 235 | 0.110 |
Why?
|
Mice | 6 | 2023 | 81183 | 0.110 |
Why?
|
Opportunistic Infections | 1 | 2016 | 389 | 0.110 |
Why?
|
RNA, Small Interfering | 1 | 2022 | 3505 | 0.110 |
Why?
|
Serotonin | 1 | 2017 | 1017 | 0.110 |
Why?
|
Aged, 80 and over | 8 | 2017 | 57776 | 0.110 |
Why?
|
Rhodamines | 1 | 2013 | 183 | 0.110 |
Why?
|
DNA, Bacterial | 1 | 2017 | 1465 | 0.110 |
Why?
|
Colony Count, Microbial | 2 | 2010 | 331 | 0.110 |
Why?
|
Blood Coagulation | 1 | 2018 | 1127 | 0.110 |
Why?
|
Health Care Surveys | 1 | 2020 | 2453 | 0.110 |
Why?
|
Polymers | 1 | 2019 | 1621 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1855 | 0.100 |
Why?
|
Particulate Matter | 2 | 2020 | 2530 | 0.100 |
Why?
|
Immunoglobulin E | 1 | 2018 | 1463 | 0.100 |
Why?
|
Rats, Sprague-Dawley | 3 | 2021 | 8301 | 0.100 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1477 | 0.100 |
Why?
|
Nasal Sprays | 1 | 2011 | 18 | 0.100 |
Why?
|
Tumor Burden | 1 | 2017 | 1915 | 0.100 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2007 | 4034 | 0.100 |
Why?
|
Gels | 1 | 2013 | 427 | 0.100 |
Why?
|
Cranial Fossa, Anterior | 1 | 2011 | 13 | 0.100 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2020 | 2015 | 0.100 |
Why?
|
Viral Load | 1 | 2020 | 3299 | 0.100 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2017 | 1121 | 0.100 |
Why?
|
Accessory Nerve | 1 | 2011 | 11 | 0.100 |
Why?
|
Lasers, Semiconductor | 1 | 2011 | 46 | 0.100 |
Why?
|
Synaptic Transmission | 1 | 2017 | 1178 | 0.100 |
Why?
|
Lung | 1 | 2010 | 9856 | 0.100 |
Why?
|
Hippocampus | 1 | 2024 | 3675 | 0.100 |
Why?
|
Diffusion | 1 | 2013 | 833 | 0.100 |
Why?
|
Down-Regulation | 1 | 2018 | 3002 | 0.100 |
Why?
|
Immunocompromised Host | 1 | 2016 | 847 | 0.100 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2015 | 450 | 0.100 |
Why?
|
Zenker Diverticulum | 1 | 2010 | 20 | 0.100 |
Why?
|
Dextrans | 1 | 2013 | 595 | 0.100 |
Why?
|
Facial Nerve Injuries | 1 | 2011 | 63 | 0.100 |
Why?
|
Signal Transduction | 3 | 2018 | 23403 | 0.100 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2014 | 349 | 0.100 |
Why?
|
Electrophoresis | 1 | 2011 | 240 | 0.100 |
Why?
|
Molecular Weight | 1 | 2013 | 2255 | 0.090 |
Why?
|
Oropharynx | 1 | 2011 | 127 | 0.090 |
Why?
|
Immunomodulation | 1 | 2014 | 541 | 0.090 |
Why?
|
Debridement | 2 | 2015 | 492 | 0.090 |
Why?
|
Protein Processing, Post-Translational | 1 | 2018 | 1990 | 0.090 |
Why?
|
Dopamine | 1 | 2017 | 1591 | 0.090 |
Why?
|
Mucociliary Clearance | 1 | 2010 | 67 | 0.090 |
Why?
|
Patient Care Planning | 1 | 2016 | 921 | 0.090 |
Why?
|
Phenotype | 3 | 2019 | 16365 | 0.090 |
Why?
|
Occupational Exposure | 1 | 2020 | 1796 | 0.090 |
Why?
|
Fibrin Tissue Adhesive | 1 | 2010 | 85 | 0.090 |
Why?
|
Sampling Studies | 1 | 2011 | 623 | 0.090 |
Why?
|
Cell Communication | 1 | 2017 | 1621 | 0.090 |
Why?
|
Head and Neck Neoplasms | 1 | 2024 | 2734 | 0.090 |
Why?
|
Nitric Oxide | 1 | 2018 | 2132 | 0.090 |
Why?
|
Cytoplasm | 1 | 2014 | 1539 | 0.090 |
Why?
|
Welding | 1 | 2010 | 89 | 0.090 |
Why?
|
Pliability | 1 | 2009 | 63 | 0.080 |
Why?
|
Gentamicins | 1 | 2010 | 255 | 0.080 |
Why?
|
Spinal Puncture | 1 | 2011 | 281 | 0.080 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2014 | 1375 | 0.080 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 3610 | 0.080 |
Why?
|
Tissue Adhesives | 1 | 2010 | 179 | 0.080 |
Why?
|
Pain, Postoperative | 1 | 2018 | 1643 | 0.080 |
Why?
|
Fungi | 1 | 2011 | 327 | 0.080 |
Why?
|
Neurosurgical Procedures | 1 | 2019 | 2002 | 0.080 |
Why?
|
Parkinson Disease | 1 | 2022 | 2775 | 0.080 |
Why?
|
Mycoses | 1 | 2011 | 376 | 0.080 |
Why?
|
Cilia | 1 | 2011 | 466 | 0.080 |
Why?
|
Tensile Strength | 1 | 2008 | 335 | 0.080 |
Why?
|
Societies, Medical | 1 | 2020 | 3743 | 0.080 |
Why?
|
Immunologic Factors | 1 | 2017 | 1580 | 0.080 |
Why?
|
Sodium Chloride | 1 | 2009 | 625 | 0.070 |
Why?
|
Biopsy | 3 | 2011 | 6756 | 0.070 |
Why?
|
Cranial Fossa, Middle | 1 | 2006 | 28 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 5 | 2020 | 35421 | 0.070 |
Why?
|
Corpus Striatum | 1 | 2013 | 1221 | 0.070 |
Why?
|
Chemokines | 1 | 2011 | 970 | 0.070 |
Why?
|
Vancomycin | 1 | 2010 | 501 | 0.070 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2009 | 362 | 0.070 |
Why?
|
MicroRNAs | 1 | 2022 | 3752 | 0.070 |
Why?
|
RNA, Ribosomal, 16S | 2 | 2020 | 954 | 0.070 |
Why?
|
Intraoperative Care | 1 | 2010 | 767 | 0.070 |
Why?
|
Cyst Fluid | 1 | 2006 | 76 | 0.070 |
Why?
|
Deglutition | 1 | 2007 | 197 | 0.070 |
Why?
|
Disease Management | 1 | 2017 | 2459 | 0.070 |
Why?
|
Iatrogenic Disease | 1 | 2008 | 547 | 0.060 |
Why?
|
Hyaluronic Acid | 1 | 2008 | 491 | 0.060 |
Why?
|
Mass Screening | 1 | 2020 | 5255 | 0.060 |
Why?
|
Primary Health Care | 1 | 2021 | 4558 | 0.060 |
Why?
|
Antineoplastic Agents | 1 | 2007 | 13695 | 0.060 |
Why?
|
Biofilms | 1 | 2009 | 617 | 0.060 |
Why?
|
Databases, Factual | 2 | 2016 | 7729 | 0.060 |
Why?
|
Adolescent | 4 | 2019 | 85781 | 0.060 |
Why?
|
Eosinophil-Derived Neurotoxin | 1 | 2023 | 13 | 0.060 |
Why?
|
Odds Ratio | 1 | 2016 | 9849 | 0.060 |
Why?
|
RNA, Messenger | 1 | 2019 | 13033 | 0.060 |
Why?
|
Patient Selection | 1 | 2016 | 4215 | 0.060 |
Why?
|
Postoperative Care | 1 | 2010 | 1486 | 0.060 |
Why?
|
Software | 1 | 2017 | 4443 | 0.060 |
Why?
|
Drug Combinations | 1 | 2009 | 1959 | 0.060 |
Why?
|
Sensitivity and Specificity | 2 | 2011 | 14722 | 0.060 |
Why?
|
Adjuvants, Immunologic | 1 | 2008 | 1000 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 25043 | 0.060 |
Why?
|
Dendritic Cells | 2 | 2011 | 2725 | 0.060 |
Why?
|
Gene Expression Regulation | 2 | 2018 | 12072 | 0.050 |
Why?
|
Asthma | 2 | 2020 | 6011 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2018 | 3674 | 0.050 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2007 | 1770 | 0.050 |
Why?
|
Central Nervous System Agents | 1 | 2022 | 72 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8642 | 0.050 |
Why?
|
Radionuclide Imaging | 1 | 2006 | 2031 | 0.050 |
Why?
|
Prosthesis Design | 1 | 2009 | 2110 | 0.050 |
Why?
|
Transillumination | 1 | 2021 | 21 | 0.050 |
Why?
|
Risk Factors | 5 | 2020 | 72290 | 0.050 |
Why?
|
DNA, Viral | 1 | 2008 | 2225 | 0.050 |
Why?
|
Immunosuppressive Agents | 1 | 2014 | 4149 | 0.050 |
Why?
|
Double-Blind Method | 1 | 2015 | 12026 | 0.050 |
Why?
|
Child | 3 | 2020 | 77709 | 0.050 |
Why?
|
Oligonucleotides, Antisense | 1 | 2022 | 433 | 0.050 |
Why?
|
National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2020 | 62 | 0.050 |
Why?
|
Staphylococcus | 1 | 2020 | 155 | 0.040 |
Why?
|
Chi-Square Distribution | 1 | 2006 | 3508 | 0.040 |
Why?
|
Time Factors | 2 | 2013 | 40075 | 0.040 |
Why?
|
Neuroendoscopy | 1 | 2020 | 105 | 0.040 |
Why?
|
Carbocyanines | 1 | 2018 | 174 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2011 | 3327 | 0.040 |
Why?
|
Pregnancy | 1 | 2020 | 29144 | 0.040 |
Why?
|
Cytological Techniques | 1 | 2019 | 219 | 0.040 |
Why?
|
Nanotechnology | 1 | 2023 | 710 | 0.040 |
Why?
|
Polyethylene Glycols | 1 | 2023 | 1182 | 0.040 |
Why?
|
Disulfides | 1 | 2018 | 457 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2011 | 3507 | 0.040 |
Why?
|
Stereotaxic Techniques | 1 | 2018 | 536 | 0.040 |
Why?
|
Silicone Elastomers | 1 | 2016 | 84 | 0.030 |
Why?
|
Methionine | 1 | 2018 | 590 | 0.030 |
Why?
|
Infant | 1 | 2017 | 35136 | 0.030 |
Why?
|
Mucorales | 1 | 2015 | 33 | 0.030 |
Why?
|
Aspergillus | 1 | 2015 | 85 | 0.030 |
Why?
|
Microscopy | 1 | 2020 | 903 | 0.030 |
Why?
|
Silicones | 1 | 2016 | 250 | 0.030 |
Why?
|
Models, Biological | 1 | 2011 | 9583 | 0.030 |
Why?
|
Risk Assessment | 1 | 2016 | 23338 | 0.030 |
Why?
|
Recurrence | 1 | 2006 | 8340 | 0.030 |
Why?
|
Comorbidity | 2 | 2020 | 10388 | 0.030 |
Why?
|
Hyperbaric Oxygenation | 1 | 2015 | 163 | 0.030 |
Why?
|
Transfection | 1 | 2022 | 5892 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2018 | 1100 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2010 | 6234 | 0.030 |
Why?
|
Cysteine | 1 | 2018 | 874 | 0.030 |
Why?
|
Occupational Health | 1 | 2020 | 809 | 0.030 |
Why?
|
Operating Rooms | 1 | 2020 | 817 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2016 | 767 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2018 | 2124 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2018 | 970 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2017 | 1616 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2018 | 2187 | 0.030 |
Why?
|
Incidence | 1 | 2011 | 20947 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1782 | 0.030 |
Why?
|
Algorithms | 1 | 2013 | 13881 | 0.030 |
Why?
|
Child, Preschool | 1 | 2015 | 41006 | 0.030 |
Why?
|
Ligation | 1 | 2013 | 453 | 0.030 |
Why?
|
Consensus | 1 | 2021 | 2959 | 0.030 |
Why?
|
Th1-Th2 Balance | 1 | 2011 | 38 | 0.020 |
Why?
|
Bandages | 1 | 2013 | 266 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2016 | 1641 | 0.020 |
Why?
|
Logistic Models | 1 | 2006 | 13408 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2016 | 2971 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2886 | 0.020 |
Why?
|
Electrodiagnosis | 1 | 2011 | 151 | 0.020 |
Why?
|
Blood Circulation | 1 | 2011 | 251 | 0.020 |
Why?
|
Organ Size | 1 | 2015 | 2252 | 0.020 |
Why?
|
Cathelicidins | 1 | 2009 | 80 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 4933 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3396 | 0.020 |
Why?
|
Intracranial Hypertension | 1 | 2010 | 186 | 0.020 |
Why?
|
Peptides | 1 | 2020 | 4409 | 0.020 |
Why?
|
Hemostasis | 1 | 2010 | 458 | 0.020 |
Why?
|
Bone Remodeling | 1 | 2011 | 575 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 6171 | 0.020 |
Why?
|
Escherichia coli | 1 | 2018 | 4217 | 0.020 |
Why?
|
Video Recording | 1 | 2011 | 949 | 0.020 |
Why?
|
Cholecalciferol | 1 | 2011 | 537 | 0.020 |
Why?
|
Calcium | 1 | 2018 | 5756 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2023 | 21827 | 0.020 |
Why?
|
Self Care | 1 | 2009 | 786 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 7913 | 0.010 |
Why?
|
Monitoring, Intraoperative | 1 | 2010 | 957 | 0.010 |
Why?
|
Robotics | 1 | 2010 | 899 | 0.010 |
Why?
|
Recovery of Function | 1 | 2011 | 2925 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2009 | 6365 | 0.010 |
Why?
|
Pilot Projects | 1 | 2011 | 8324 | 0.010 |
Why?
|
Anesthesia | 1 | 2009 | 1561 | 0.010 |
Why?
|
Macrophages | 1 | 2011 | 5655 | 0.010 |
Why?
|
Cohort Studies | 1 | 2018 | 40561 | 0.010 |
Why?
|
Body Mass Index | 1 | 2010 | 12720 | 0.010 |
Why?
|